Is the industry ready for continuous manufacturing?

Keeping the patient in mind is crucial for clinical research.

Is the pharma industry ready for another recession?

Can open source by applied to pharma R&D? This is the aim of Molecule.

Cures for all presents a real focus for the next decade – but companies must be rewarded for their work.

A new computational tool could help improve the stability and predictability of ADCs.

GE and Alderley Park are teaming up in support of SMEs in Northern England.

Jane Osbourn talks about the potential of the UK's cell and gene therapy space.

How will the adoption of novel approaches to the development of excipients help overcome the challenges of poorly soluble APIs?

How will inhaled therapies evolve? Lei Mao at Recipharm gives his take on the future of these therapies.